UNSPSC 51171645: Polyethylene glycol 400

This classification denotes a synthetic polymer with the molecular formula C2H6O2(C2H4O)N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B697894SGQ. European Medicines Agency schedules polyethylene glycol 400 in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB16380MIG. The term polyethylene glycol 400 is an International Nomenclature of Cosmetic Ingredients designation. As of Q4 2014, POLYETHYLENE GLYCOL 400 remains the US FDA Preferred Term for this commodity.

UNSPSC 51171645 Polyethylene glycol 400 is a Commodity code representing a specific chemical input used across state and local health, criminal justice, and pharmaceutical procurement contexts. The recent opportunities tagged to this code show state and local governments purchasing polyethylene glycol 400 primarily as a component within broader drug-testing specimen collection, pharmaceutical supply, and pharmacy benefit programs rather than as a standalone chemical commodity. Collin County Community Supervision and Corrections Department is soliciting offender specimen collection and drug testing services (RFP 2026-327, due July 23, 2026) with an estimated contract value of $600,000 over two years, which likely incorporates testing reagents including polyethylene glycol 400 as a specimen preservation or screening agent. The Texas Health and Human Services Commission issued an RFI (HHS0017013) in March 2026 exploring direct-to-manufacturer prescription programs, signaling interest in pharmacy supply chain optimization that could broaden polyethylene glycol 400 demand if the resulting programs include wound care, dermatological, or pharmaceutical formulation products. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) posted an RFP for generic multi-source pharmaceuticals and OTC products (S1070000015802, due March 26, 2026) serving multiple state and local facilities across Minnesota and Oregon, which may include formulated products containing polyethylene glycol 400.

Geographic activity spans Texas (Collin County and statewide HHS procurement), Minnesota, and Oregon through the MMCAP cooperative purchasing vehicle. The issuing bodies include county criminal justice agencies, state health departments, and cooperative purchasing alliances administered by state procurement offices. The Collin County RFP represents direct county procurement with a defined budget and two-year term commencing September 1, 2026, while the Texas HHS RFI and MMCAP RFP indicate broader state-level and multi-state interest in pharmaceutical and pharmaceutical-related procurement. Response activity appears limited — the source shows only three recent opportunities across the code, with only the Collin County RFP specifying a concrete contract value and timeline. Bidders should note that polyethylene glycol 400 appears to enter state and local procurement primarily as a component of larger systems (testing services, pharmaceutical formulations, or pharmacy benefit programs) rather than as a direct chemical purchase, suggesting that winning opportunities may require either supply-chain integration with testing labs, pharmaceutical manufacturers, or authorized wholesalers, or positioning as a reagent or formulation input within a larger service delivery model.